EVMN insider transactions
Evommune Inc. (EVMN) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for EVMN
- SEC Form 4 filed by Director Mcgraw Benjamin F Iii4 - Evommune, Inc. (0002044725) (Issuer)
- SEC Form 4 filed by Director Kirsch Arthur S4 - Evommune, Inc. (0002044725) (Issuer)
- Director Cohen David E sold $123,094 worth of shares (6,056 units at $20.33) as part of a pre-agreed trading plan, decreasing direct ownership by 26% to 17,609 units (SEC Form 4)4 - Evommune, Inc. (0002044725) (Issuer)
- Chief Scientific Officer Patel Jeegar Pravinkumar sold $379,462 worth of shares (16,687 units at $22.74) as part of a pre-agreed trading plan and exercised 13,512 shares at a strike of $3.84, decreasing direct ownership by 6% to 46,403 units (SEC Form 4)4 - Evommune, Inc. (0002044725) (Issuer)
- President & CEO Pena Luis C. sold $381,736 worth of shares (16,787 units at $22.74) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 637,896 units (SEC Form 4)4 - Evommune, Inc. (0002044725) (Issuer)
- Chief Business & Legal Officer Moss Gregory S. exercised 14,223 shares at a strike of $1.71 and sold $324,711 worth of shares (14,223 units at $22.83) as part of a pre-agreed trading plan (SEC Form 4)4 - Evommune, Inc. (0002044725) (Issuer)
- Chief Financial Officer Carver Kyle exercised 15,000 shares at a strike of $2.99 and sold $415,117 worth of shares (18,175 units at $22.84) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 59,335 units (SEC Form 4)4 - Evommune, Inc. (0002044725) (Issuer)
- SEC Form 4 filed by Patel Jeegar Pravinkumar4 - Evommune, Inc. (0002044725) (Issuer)
- SEC Form 4 filed by Drew Janice Suzann4 - Evommune, Inc. (0002044725) (Issuer)
- SEC Form 4 filed by Bauer Eugene4 - Evommune, Inc. (0002044725) (Issuer)
- SEC Form 4 filed by Carver Kyle4 - Evommune, Inc. (0002044725) (Issuer)
- SEC Form 4 filed by Moss Gregory S.4 - Evommune, Inc. (0002044725) (Issuer)
- SEC Form 4 filed by Pena Luis C.4 - Evommune, Inc. (0002044725) (Issuer)
- Director Lsp 7 Cooperative Ua was granted 358,680 shares (SEC Form 4)4 - Evommune, Inc. (0002044725) (Issuer)
- Director Verduyn-Van Weegen Felice Isabel was granted 358,680 shares (SEC Form 4)4 - Evommune, Inc. (0002044725) (Issuer)
- Director Ra Capital Management, L.P. was granted 35,868 shares (SEC Form 4)4 - Evommune, Inc. (0002044725) (Issuer)
- Director Hopfner Robert Lorne bought $17,350 worth of shares (1,000 units at $17.35) (SEC Form 4)4 - Evommune, Inc. (0002044725) (Issuer)
- SEC Form 4 filed by Chief Medical Officer Bauer Eugene4 - Evommune, Inc. (0002044725) (Issuer)
- President & CEO Pena Luis C. covered exercise/tax liability with 28,138 shares, decreasing direct ownership by 4% to 654,683 units (SEC Form 4)4 - Evommune, Inc. (0002044725) (Issuer)
- Chief Scientific Officer Patel Jeegar Pravinkumar covered exercise/tax liability with 7,513 shares, decreasing direct ownership by 13% to 49,578 units (SEC Form 4)4 - Evommune, Inc. (0002044725) (Issuer)
- Chief Business & Legal Officer Moss Gregory S. covered exercise/tax liability with 13,624 shares, decreasing direct ownership by 18% to 60,835 units (SEC Form 4)4 - Evommune, Inc. (0002044725) (Issuer)
- EVP, Operations Drew Janice Suzann covered exercise/tax liability with 5,074 shares, decreasing direct ownership by 7% to 67,794 units (SEC Form 4)4 - Evommune, Inc. (0002044725) (Issuer)
- Chief Financial Officer Carver Kyle covered exercise/tax liability with 13,290 shares, decreasing direct ownership by 18% to 62,510 units (SEC Form 4)4 - Evommune, Inc. (0002044725) (Issuer)
- Chief Medical Officer Bauer Eugene covered exercise/tax liability with 1,478 shares, decreasing direct ownership by 0.54% to 270,818 units (SEC Form 4)4 - Evommune, Inc. (0002044725) (Issuer)